J. Goldman & Co’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.5K | Hold |
13,500
| – | – | ﹤0.01% | 306 |
|
|
2025
Q1 | $50.8K | Hold |
13,500
| – | – | ﹤0.01% | 301 |
|
|
2024
Q4 | $78.7K | Sell |
13,500
-20,250
| -60% | -$118K | ﹤0.01% | 305 |
|
|
2024
Q3 | $403K | Buy |
+33,750
| New | +$403K | 0.01% | 260 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 413 |
|
|
2024
Q1 | – | Sell |
-50,766
| Closed | -$712K | – | 360 |
|
|
2023
Q4 | $712K | Buy |
50,766
+19,434
| +62% | +$273K | 0.03% | 158 |
|
|
2023
Q3 | $387K | Sell |
31,332
-77,058
| -71% | -$952K | 0.01% | 187 |
|
|
2023
Q2 | $979K | Sell |
108,390
-338,693
| -76% | -$3.06M | 0.04% | 166 |
|
|
2023
Q1 | $1.55M | Sell |
447,083
-68,494
| -13% | -$238K | 0.06% | 155 |
|
|
2022
Q4 | $1.26M | Buy |
+515,577
| New | +$1.26M | 0.06% | 157 |
|